Literature DB >> 7309012

Measuring chronic schizophrenic patients attitudes toward their illness and treatment.

J P McEvoy, J Aland, W H Wilson, W Guy, L Hawkins.   

Abstract

The right to refuse medication is a legal right now being extended by federal courts to many voluntary and involuntary mental patients. However, little is known of the insight that chronically ill mental patients bring to the decision of whether or not to accept prescribed medication. In this study, the authors interviewed 45 chronic schizophrenic inpatients to determine their understanding of their illness, need for admission, and need for medication and other treatment. Only 13 per cent understood they were mentally ill, and only 27 per cent of the patients understood that they needed medication. The findings suggest that many chronically mentally ill patients lack sufficient insight into their condition to make sound judgments about medication and treatment. Moreover, even those patients who improved with medication did not improve in their insight into their need for treatment.

Entities:  

Mesh:

Year:  1981        PMID: 7309012     DOI: 10.1176/ps.32.12.856

Source DB:  PubMed          Journal:  Hosp Community Psychiatry        ISSN: 0022-1597


  21 in total

1.  The neuroanatomical correlates of cognitive insight in schizophrenia.

Authors:  Maria Donata Orfei; Fabrizio Piras; Enrica Macci; Carlo Caltagirone; Gianfranco Spalletta
Journal:  Soc Cogn Affect Neurosci       Date:  2012-01-28       Impact factor: 3.436

2.  Clinical characteristics of individuals with serious mental illness and type 2 diabetes.

Authors:  Martha Sajatovic; Douglas Gunzler; Douglas Einstadter; Charles Thomas; Richard A McCormick; Adam T Perzynski; Stephanie Kanuch; Kristin A Cassidy; Neal V Dawson
Journal:  Psychiatr Serv       Date:  2014-11-17       Impact factor: 3.084

Review 3.  Consumer satisfaction with institutional and community care.

Authors:  P W Corrigan
Journal:  Community Ment Health J       Date:  1990-04

Review 4.  Insight in schizophrenia: a review.

Authors:  Marjorie Baier
Journal:  Curr Psychiatry Rep       Date:  2010-08       Impact factor: 5.285

5.  A Randomized Controlled Trial of the Rochester Forensic Assertive Community Treatment Model.

Authors:  J Steven Lamberti; Robert L Weisman; Catherine Cerulli; Geoffrey C Williams; David B Jacobowitz; Kim T Mueser; Patricia D Marks; Robert L Strawderman; Donald Harrington; Tara A Lamberti; Eric D Caine
Journal:  Psychiatr Serv       Date:  2017-06-01       Impact factor: 3.084

6.  Medication treatment perceptions, concerns and expectations among depressed individuals with Type I Bipolar Disorder.

Authors:  Martha Sajatovic; Janis H Jenkins; Kristin A Cassidy; David J Muzina
Journal:  J Affect Disord       Date:  2008-11-08       Impact factor: 4.839

7.  Suicide attempt and suicidal ideation and their associations with demographic and clinical correlates and quality of life in Chinese schizophrenia patients.

Authors:  Fang Yan; Yu-Tao Xiang; Ye-Zhi Hou; Gabor S Ungvari; Lisa B Dixon; Sandra S M Chan; Edwin H M Lee; Weng-Yong Li; Wen-Xiu Li; Yu-Ling Zhu; Helen F K Chiu
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-07-31       Impact factor: 4.328

8.  Predictors of nonadherence among individuals with bipolar disorder receiving treatment in a community mental health clinic.

Authors:  Martha Sajatovic; Rosalinda V Ignacio; Jane A West; Kristin A Cassidy; Roknedin Safavi; Amy M Kilbourne; Frederic C Blow
Journal:  Compr Psychiatry       Date:  2008-08-23       Impact factor: 3.735

9.  The relationship of insight to psychopathology in schizophrenia: a cross-sectional study.

Authors:  V M Aga; A K Agarwal; S C Gupta
Journal:  Indian J Psychiatry       Date:  1995-07       Impact factor: 1.759

10.  Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia.

Authors:  Jeffrey W Swanson; Marvin S Swartz; Richard A Van Dorn; Jan Volavka; John Monahan; T Scott Stroup; Joseph P McEvoy; H Ryan Wagner; Eric B Elbogen; Jeffrey A Lieberman
Journal:  Br J Psychiatry       Date:  2008-07       Impact factor: 9.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.